• LAST PRICE
    1.9200
  • TODAY'S CHANGE (%)
    Trending Down-0.0200 (-1.0309%)
  • Bid / Lots
    1.9000/ 40
  • Ask / Lots
    2.4000/ 4
  • Open / Previous Close
    1.9549 / 1.9400
  • Day Range
    Low 1.9000
    High 2.0000
  • 52 Week Range
    Low 1.2000
    High 5.1400
  • Volume
    19,866
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.94
TimeVolumePETV
10:01 ET10051.9549
10:28 ET29961.9003
10:32 ET2001.95
10:51 ET10001.9544
11:02 ET47872
11:13 ET2001.96
12:43 ET1002
12:45 ET6002
12:54 ET2001.99
01:08 ET4002
01:10 ET15131.9901
01:53 ET2001.99
02:42 ET20421.99
03:39 ET22001.95
03:54 ET10001.9357
03:59 ET3141.92
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPETV
PetVivo Holdings Inc
19.2M
-2.9x
---
United StatesTNON
Tenon Medical Inc
15.1M
-1.0x
---
United StatesBJDX
Bluejay Diagnostics Inc
16.4M
-2.4x
---
United StatesRNXT
RenovoRx Inc
17.2M
-1.5x
---
United StatesWHSI
Wearable Health Solutions Inc
15.4M
0.0x
---
United StatesCTGL
Citrine Global Corp
22.6M
-8.6x
---
As of 2022-10-01

Company Information

PetVivo Holdings, Inc. is a development-stage company. The Company is a biomedical device company focused on licensing and commercialization of medical devices and therapeutics for pets. The Company's operating subsidiary, PetVivo, Inc., (PetVivo) is engaged in the business of acquiring/in-licensing and adapting human biomedical technology and products for commercial sale in the veterinary market to treat pets and other animals suffering from arthritis and other painful affliction. As of March 31, 2015, PetVivo's pipeline included 17 therapeutic devices for both veterinary and human clinical applications. PetVivo's pipeline includes VD-01, VD-02 and VD-06, which are indicated for osteoarthritis, and VD-04, which is indicated for urinary incontinence, among others. Its subsidiary also includes Gel-Del Technologies, Inc., which has completed a pivotal clinical trial using their thermoplastic biomaterial as a dermal filler for human cosmetic applications.

Contact Information

Headquarters
5251 Edina Industrial BlvdEDINA, MN, United States 55439
Phone
952-217-4952
Fax
775-884-9383

Executives

Non-Executive Independent Chairman of the Board
Gregory Cash
President, Chief Executive Officer, Director
John Lai
Chief Financial Officer
Robert Folkes
Chief Operating Officer, Director
Randall Meyer
Vice President - Business Development, General Counsel, Company Secretary, Director
John Dolan

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$19.2M
Revenue (TTM)
$169.6K
Shares Outstanding
10.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.83
EPS
$-0.67
Book Value
$0.60
P/E Ratio
-2.9x
Price/Sales (TTM)
113.1
Price/Cash Flow (TTM)
---
Operating Margin
-3,834.74%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.